Alterity Therapeutics (ATHE) Depreciation and Depletion (2009 - 2025)
Alterity Therapeutics' (ATHE) quarterly Depreciation and Depletion came in at -$2790.4 in Q4 2025, up 87.35% year-on-year from -$1489.5 in Q4 2024, and up 87.35% quarter-over-quarter from -$22054.0 in Q4 2024.
Alterity Therapeutics (ATHE) Depreciation and Depletion (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Depreciation and Depletion history runs 14 years deep, the most recent figure standing at -$2790.4 for Q4 2025.
- On a quarterly basis, Depreciation and Depletion rose 87.35% year-over-year to -$2790.4 in Q4 2025; TTM through Dec 2025 was -$74592.2, a 8.39% increase from a year earlier, with the FY2025 full-year figure at $71349.4, down 100.0% from the prior year.
- Depreciation and Depletion advanced to -$2790.4 in Q4 2025 per ATHE's latest filing, from -$22054.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at -$2790.4 in Q4 2025 and bottomed at -$25849.9 in Q4 2022.
- The 5-year median for Depreciation and Depletion is -$22054.0 (2024), against an average of -$16842.3.
- Across the five-year window, Depreciation and Depletion slumped 168.73% in 2022 and soared 87.35% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at -$9619.1 in 2021, then slumped by 168.73% to -$25849.9 in 2022, then climbed by 7.55% to -$23897.9 in 2023, then gained by 7.72% to -$22054.0 in 2024, then surged by 87.35% to -$2790.4 in 2025.
- Per Business Quant, the three latest ATHE Depreciation and Depletion figures stand at -$2790.4 (Q4 2025), -$22054.0 (Q4 2024), and -$23897.9 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - | -2,790.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,790.45 |
| Dec 31, 2025 | -2,790.45 |
| Dec 31, 2024 | -22,054.03 |
| Dec 31, 2024 | -22,054.03 |
| Dec 31, 2023 | -23,897.86 |
| Dec 31, 2023 | -23,897.86 |
| Dec 31, 2022 | -25,849.87 |
| Dec 31, 2022 | -25,849.87 |
| Dec 31, 2021 | -9,619.12 |
| Dec 31, 2021 | -9,619.12 |
| Jun 30, 2020 | 17,033.07 |
| Jun 30, 2020 | 17,033.07 |
| Dec 31, 2019 | -39,090.02 |
| Dec 31, 2019 | -39,090.02 |
| Jun 30, 2019 | 20,801.22 |
| Jun 30, 2019 | 20,801.22 |
| Dec 31, 2018 | 10,527.79 |
| Dec 31, 2018 | 10,527.79 |
| Jun 30, 2018 | 165.03 |
| Jun 30, 2018 | 165.03 |